Conserved complement binding to bacterial porins
与细菌孔蛋白结合的保守补体
基本信息
- 批准号:8772309
- 负责人:
- 金额:$ 23.1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-07-01 至 2016-06-30
- 项目状态:已结题
- 来源:
- 关键词:AcinetobacterAmericanBacteriaBacterial InfectionsBindingBiochemical GeneticsBiologyBlood CirculationBurn injuryC-terminalCell surfaceClinicalComplementDataDeletion MutagenesisDiagnosisDiffusionDiseaseEpidemiologyEscherichia coliEventGenetic HeterogeneityGoalsGram-Negative BacteriaHealthHospitalsHost DefenseHumanImmuneInfectionLeadLegionellaLigandsLinkLungMapsMasksMediatingMembraneMolecularMutagenesisOrganismPathogenesisPathway interactionsPatternPhagocytesPolysaccharidesPreventionProteinsPseudomonas aeruginosaPublishingRecombinantsRelative (related person)ResearchResistanceRoleSalmonellaSepsisSerumStructureSurfaceTestingTherapeutic AgentsVirulenceWorkbasecomplement C3 precursorcomplement systemdesignimprovedinsightkillingsnovel therapeuticspathogenporinpreventpublic health relevanceresearch studysmall moleculesolutetraittreatment strategyvaccine candidate
项目摘要
DESCRIPTION (provided by applicant): This application seeks to define the molecular mechanism of complement C3 binding interactions with bacterial surfaces. Specifically we will evaluate how Pseudomonas aeruginosa C3 binding to an outer membrane porin (OprF) promotes phagocyte interactions and how this may be exploited to enhance opsonophagocytosis and complement-mediated killing. We also discovered that the C-terminal region of P. aeruginosa OprF has high structural identity with the OmpA domain of several other Gram- negative bacteria, one of which is known to bind C3. Therefore, this study will not only contribute to an understanding of P. aeruginosa pathogenesis but also provide insights into the biology of complement interactions in other Gram-negative bacteria. This will, in turn, lead to new and more effective strategies for the treatment or prevention of P. aeruginosa and perhaps other Gram-negative infections. This proposal will use state-of-the art molecular, biochemical, and genetic approaches to probe interactions of complement and Gram-negative porins. To date, the mechanistic basis for resistance to complement-mediated killing of P. aeruginosa is not completely understood. We recently discovered that OprF is one ligand recognized by human complement C3. Aim 1 will evaluate conservation of OprF-C3 binding and Psl masking among P. aeruginosa clinical isolates. The goal of Aim 2 is to determine if OprF levels can be modulated to improve serum-mediated killing. Aim 3 will focus on mapping regions of OprF that are required for C3 interactions. Finally, in Aim 4 we will evaluate conservation of C3 interaction
with surface exposed porin domains in other Gram-negative pathogens. Understanding the molecular mechanism of C3 binding to bacterial surfaces offers a potential means for preventing and/or treating diseases caused by these Gram-negative pathogens.
描述(由申请人提供):本应用程序旨在定义补体C3结合与细菌表面的分子机制。具体而言,我们将评估铜绿假单胞菌C3与外膜孔蛋白(OPRF)的结合如何促进吞噬细胞相互作用,以及如何利用这种相互作用以增强吞噬性吞噬作用和补体介导的杀戮。我们还发现,铜绿假单胞菌OPRF的C末端区域与其他几种革兰氏阴性细菌的OMPA结构域具有很高的结构同一性,其中一种已知与C3结合。因此,这项研究不仅有助于理解铜绿假单胞菌的发病机理,而且还提供了对其他革兰氏阴性细菌补体相互作用的生物学的见解。反过来,这将为治疗或预防铜绿假单胞菌以及其他革兰氏阴性感染提供新的,更有效的策略。该提案将使用最先进的分子,生化和遗传方法来探测补体和革兰氏阴性孔的相互作用。迄今为止,尚不完全了解抗铜绿假单胞菌杀死的抵抗力的机理基础。我们最近发现,OPRF是人类补体C3认可的配体。 AIM 1将评估铜绿假单胞菌临床分离株之间OPRF-C3结合和PSL掩盖的保存。 AIM 2的目标是确定是否可以调节OPRF水平以改善血清介导的杀戮。 AIM 3将集中于C3交互所需的OPRF区域。最后,在AIM 4中,我们将评估C3相互作用的保护
在其他革兰氏阴性病原体中具有表面暴露的孔蛋白结构域。了解C3与细菌表面结合的分子机制提供了预防和/或治疗由这些革兰氏阴性病原体引起的疾病的潜在手段。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Daniel J Wozniak其他文献
Daniel J Wozniak的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Daniel J Wozniak', 18)}}的其他基金
The impact of bacteriophage therapy on wound infection dynamics
噬菌体疗法对伤口感染动态的影响
- 批准号:
10467125 - 财政年份:2022
- 资助金额:
$ 23.1万 - 项目类别:
The impact of bacteriophage therapy on wound infection dynamics
噬菌体疗法对伤口感染动态的影响
- 批准号:
10560606 - 财政年份:2022
- 资助金额:
$ 23.1万 - 项目类别:
The essential P. aeruginosa pan-genome during chronic infection
慢性感染过程中必需的铜绿假单胞菌全基因组
- 批准号:
8623447 - 财政年份:2013
- 资助金额:
$ 23.1万 - 项目类别:
The essential P. aeruginosa pan-genome during chronic infection
慢性感染过程中必需的铜绿假单胞菌全基因组
- 批准号:
8780593 - 财政年份:2013
- 资助金额:
$ 23.1万 - 项目类别:
相似海外基金
AstraDx: Sub-Hour AST Via Computational Image Processing
AstraDx:通过计算图像处理实现不到一小时的 AST
- 批准号:
10670875 - 财政年份:2022
- 资助金额:
$ 23.1万 - 项目类别:
AstraDx: Sub-Hour AST Via Computational Image Processing
AstraDx:通过计算图像处理实现不到一小时的 AST
- 批准号:
10547198 - 财政年份:2022
- 资助金额:
$ 23.1万 - 项目类别:
Genomics-Assisted Antibiotic Discovery from Unprecedented Microbes of the Great Salt Lake
基因组学辅助从大盐湖前所未有的微生物中发现抗生素
- 批准号:
10298732 - 财政年份:2021
- 资助金额:
$ 23.1万 - 项目类别:
Genomics-Assisted Antibiotic Discovery from Unprecedented Microbes of the Great Salt Lake
基因组学辅助从大盐湖前所未有的微生物中发现抗生素
- 批准号:
10663207 - 财政年份:2021
- 资助金额:
$ 23.1万 - 项目类别:
Genomics-Assisted Antibiotic Discovery from Unprecedented Microbes of the Great Salt Lake
基因组学辅助从大盐湖前所未有的微生物中发现抗生素
- 批准号:
10448339 - 财政年份:2021
- 资助金额:
$ 23.1万 - 项目类别: